<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT><NOTICE_DATA><NO_DOC_EXT>2026-090293</NO_DOC_EXT><DOC_ID>004645-2026</DOC_ID><URI_DOC>https://www.find-tender.service.gov.uk/Notice/004645-2026</URI_DOC><PUBLISHED>2026-01-20T10:05:59Z</PUBLISHED></NOTICE_DATA><FORM_SECTION>
    <UK4_2023 FORM="UK4" LEGAL_BASIS="2023/54">
      <id>004645-2026</id>
      <date>2026-01-20T10:05:59Z</date>
      <tag>tenderUpdate</tag>
      <initiationType>tender</initiationType>
      <previousNotice>003520-2026</previousNotice>
      <ocid>ocds-h6vhtk-0606bc</ocid>
      <parties>
        <name>Healthcare Quality Improvement Partnership Ltd</name>
        <id>GB-PPON-PVVQ-6113-CJWD</id>
        <identifier>
          <scheme>GB-PPON</scheme>
          <id>PVVQ-6113-CJWD</id>
        </identifier>
        <address>
          <streetAddress>128 City Road</streetAddress>
          <locality>London</locality>
          <postalCode>EC1V 2NX</postalCode>
          <country>GB</country>
          <countryName>United Kingdom</countryName>
          <region>UKI43</region>
        </address>
        <contactPoint>
          <email>procurement@hqip.org.uk</email>
        </contactPoint>
        <roles>buyer</roles>
        <details>
          <classifications>
            <scheme>UK_CA_TYPE</scheme>
            <id>publicAuthoritySubCentralGovernment</id>
          </classifications>
        </details>
      </parties>
      <buyer>
        <id>GB-PPON-PVVQ-6113-CJWD</id>
        <name>Healthcare Quality Improvement Partnership Ltd</name>
      </buyer>
      <tender>
        <title>National Neonatal Audit Programme</title>
        <description>
          <p>The contract will initially be delivered for NHS-funded care in England, Wales, Scotland and the Isle of Man for a period of 3 years, at a maximum total budget of up to £1,233,000 GBP including VAT, £1,027,500 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years.</p>
          <p>All pricing submissions must be in regard to this &#039;core&#039; value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £1,233,000 GBP including VAT, £1,027,500 GBP excluding VAT.</p>
          <p>The maximum budget ‘core’ value is £1,233,000 GBP including VAT, £1,027,500 GBP excluding VAT excludes the potential two year extension and aspirational intent as described in section 14 of Annex A - Service Specification.</p>
          <p>Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £8,069,908 GBP including VAT.</p>
          <p>The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like.</p>
          <p>National clinical audits are expected to:</p>
          <p>a.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement</p>
          <p>b.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience</p>
          <p>c.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate</p>
          <p>d.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting</p>
          <p>e.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit</p>
          <p>f.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract</p>
          <p>g.Ensure robust methodological and statistical input at all stages of the audit</p>
          <p>h.Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly</p>
          <p>i.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data</p>
          <p>j.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget</p>
          <p>k.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups in order to drive improvements in services</p>
          <p>The anticipated outputs are:</p>
          <p>1.Near real-time dynamic and interactive metric results</p>
          <p>2.Publication of an annual state of the nation report</p>
          <p>3.Quality improvement resources </p>
          <p>4.The identification and notification of outliers</p>
          <p>Additional desirable features are set out below; however, the supplier will work with stakeholders to identify the functionalities important to them:</p>
          <p>•Presenting data via a range of graphic and tabular methods</p>
          <p>•Allowing users to define their own views (in addition to any pre-defined filters)</p>
          <p>•Functionality that compares a selected healthcare provider against other relevant comparators, and against averages for their nation, and allows the user to set their own healthcare provider comparators </p>
          <p>•Functionality for users to download the aggregate data being presented in each view, and the full set of graphs and visualisations for a chosen healthcare provider</p>
          <p>•Planning this secure, non-disclosive public data visualisation system alongside any provision of login-protected local visualisation for data to support direct care and / or local quality improvement</p>
          <p>•Presenting data on outlier status, particularly over time</p>
          <p>Further details of the current audit can be found at - https://www.rcpch.ac.uk/work-we-do/clinical-audits/nnap</p>
          <p>To respond to this opportunity, please visit https://www.delta-esourcing.com/respond/65789NT583</p>
          <p>To view this notice, please click here: </p>
          <p>https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=1007684720</p>
        </description>
        <status>active</status>
        <items>
          <id>1</id>
          <additionalClassifications>
            <scheme>CPV</scheme>
            <id>85000000</id>
          </additionalClassifications>
          <deliveryAddresses>
            <region>UK</region>
          </deliveryAddresses>
          <relatedLot>1</relatedLot>
        </items>
        <value>
          <amountGross>8069908.00</amountGross>
          <currency>GBP</currency>
        </value>
        <procurementMethod>open</procurementMethod>
        <procurementMethodDetails>Open procedure</procurementMethodDetails>
        <mainProcurementCategory>services</mainProcurementCategory>
        <aboveThreshold>true</aboveThreshold>
        <submissionMethodDetails>
          <p>https://www.delta-esourcing.com/respond/65789NT583</p>
        </submissionMethodDetails>
        <submissionTerms>
          <electronicSubmissionPolicy>allowed</electronicSubmissionPolicy>
          <languages>en</languages>
        </submissionTerms>
        <tenderPeriod>
          <endDate>2026-02-23T12:00:00+00:00</endDate>
        </tenderPeriod>
        <enquiryPeriod>
          <endDate>2026-02-09T12:00:00+00:00</endDate>
        </enquiryPeriod>
        <awardPeriod>
          <endDate>2026-07-09T23:59:59+01:00</endDate>
        </awardPeriod>
        <lots>
          <id>1</id>
          <status>active</status>
          <value>
            <amountGross>8069908.00</amountGross>
            <currency>GBP</currency>
          </value>
          <awardCriteria>
            <criteria>
              <type>quality</type>
              <name>LEADERSHIP</name>
              <numbers>
                <number>4</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC</name>
              <numbers>
                <number>8</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>STIMULATING HEALTHCARE QUALITY IMPROVEMENT</name>
              <numbers>
                <number>12</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT</name>
              <numbers>
                <number>5</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>DATA ACQUISITION STRATEGY AND BURDEN</name>
              <numbers>
                <number>12</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>INFORMATION GOVERNANCE</name>
              <numbers>
                <number>4</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>DATA QUALITY ANALYSIS</name>
              <numbers>
                <number>12</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>USES OF THE DATA</name>
              <numbers>
                <number>12</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>PROGRAMME GOVERNANCE AND DELIVERY PLAN</name>
              <numbers>
                <number>12</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>RISK MANAGEMENT</name>
              <numbers>
                <number>4</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>quality</type>
              <name>ALLOCATION OF BUDGET</name>
              <numbers>
                <number>5</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
            <criteria>
              <type>price</type>
              <name>SOCIAL VALUE</name>
              <numbers>
                <number>10</number>
                <weight>percentageExact</weight>
              </numbers>
            </criteria>
          </awardCriteria>
          <suitability>
            <sme>true</sme>
            <vcse>true</vcse>
          </suitability>
          <contractPeriod>
            <startDate>2027-04-01T00:00:00+01:00</startDate>
            <endDate>2030-03-31T23:59:59+00:00</endDate>
            <maxExtentDate>2032-03-31T23:59:59+01:00</maxExtentDate>
          </contractPeriod>
          <hasRenewal>true</hasRenewal>
          <renewal>
            <description>
              <p>Up to 2 years</p>
            </description>
          </renewal>
        </lots>
        <documents>
          <id>conflictOfInterest</id>
          <documentType>conflictOfInterest</documentType>
          <description>
            <p>Not published</p>
          </description>
          <url>https://www.find-tender.service.gov.uk/Notice/Attachment/conflictOfInterest</url>
          <format/>
        </documents>
        <documents>
          <id>A-10542</id>
          <documentType>biddingDocuments</documentType>
          <description>
            <p>This revised specification removes the indicative transition dates for the transition tasks previous published under section 14.2 of the specification.</p>
            <p>Any transition tasks detailed in section 14.2 of this revised specification should be included within the tendered proposal and cost envelope.</p>
          </description>
          <url>https://www.find-tender.service.gov.uk/Notice/Attachment/A-10542</url>
          <format>application/vnd.openxmlformats-officedocument.wordprocessingml.document</format>
        </documents>
        <riskDetails>
          <p>Full descriptive details of these measures, as well as the mechanisms for invoking them can be found in section 14 of Annex A - Service Specification.</p>
          <p>All figures are inclusive of VAT</p>
          <p>Up to 24-month extension that mirrors the NCAPOP headline contract. - Up to £822,000 plus a pro-rata of any costs invoked under aspirational intent</p>
          <p>Inclusion of additional clinical audits and/or Clinical Outcome Review Programmes (CORP). - Up to £1,440,000</p>
          <p>Transition to different models of data collection/outputs &amp;/or operational methods/processes for the audit.  - Up to £631,080</p>
          <p>Extending specific service coverage to include privately funded care. - Up to £360,000</p>
          <p>Additions or enhancements to the service delivery of the project. - Up to £1,200,000</p>
          <p>Additional quality improvement initiatives either related to or linked with the project. - Up to £360,000</p>
          <p>Changes in line with national policy. - Up to £1,200,000</p>
          <p>Providing information on national rates of brain injury in in preterm and term babies. - Up to £375,000</p>
          <p>HQIP also allow additional devolved nations / crown dependencies (not listed in the service specification) to join programmes. The below figures are based off the Barnett formula, and are the maximum values exclusive of VAT.</p>
          <p>Set up and development fees for additional national or international funders. - Up to £96,000</p>
          <p>Northern Ireland - Up to £201,683</p>
          <p>Guernsey - Up to £6,642</p>
          <p>Jersey - Up to £9,961</p>
        </riskDetails>
      </tender>
      <language>en</language>
    </UK4_2023>
  </FORM_SECTION></TED_EXPORT>
